Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 30 recruiting now early-phase tilt

Ischemic Stroke: early-phase trial registry

30 of 67 indexed Ischemic Stroke trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #208 of 28,707 conditions by registered trial count.

67 US clinical trials · 30 currently recruiting · #208 of 28,707 conditions by registered trial count

Ischemic Stroke: 67 US clinical trials tracked, 30 recruiting.

Ischemic Stroke is the subject of 67 registered US clinical trials on ClinicalTrials.gov, 30 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 4 of these trials.

Enrollment posture brief

Registry condition ischemic-stroke

OPEN 30 | RECR 45% | LATE 3 | EARLY 19 | RANK #208 | SPON 4

Nearest open-share peer: Food Insecurity (45% recruiting · 38 trials)

Brain Metastases60.3%Ischemic Stroke (this)45%Parenting40.3%Alcoholism16.4%Acne Vulgaris2.9%
Open-enrollment share among volume-matched conditions near Ischemic Stroke

Ischemic Stroke lists 30 open slots (45% of 67 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ischemic Stroke on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ischemic Stroke is recruiting above its size-band peers.

    30 of 67 indexed trials (44.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Ischemic Stroke trials is spread across many organizations.

    Johns Hopkins University accounts for 4 of 67 trials (6%). 52 distinct sponsors appear on at least one study for this condition label.

  3. Typical Ischemic Stroke enrolment sits around 83 participants.

    Median target enrolment is 83 among the 67 trials that report a genuine target (sentinel values excluded). 35 of those (52.2%) plan for fewer than 100 participants.

  4. Ischemic Stroke research is mostly interventional.

    48 interventional and 19 observational studies make up this index (71.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 110Phase 29Phase 43

Open and recent trials

67 total, page 1 of 2

RECRUITING 60,000 participants

Stroke Recovery Initiative - Registry for Stroke Research Studies

University of California, San Francisco

NCT03318432

RECRUITING 8,000 participants

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Massachusetts General Hospital

NCT04916210

RECRUITING 3,000 participants

Transitions of Care for Stroke Patients

Kiwon Lee MD

NCT06011720

RECRUITING NA 1,600 participants

StrokeNet Thrombectomy Endovascular Platform

Medical University of South Carolina

NCT06289985

RECRUITING 900 participants

Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders

Cedars-Sinai Medical Center

NCT02910180

RECRUITING NA 842 participants

CTSN Embolic Protection Trial

Icahn School of Medicine at Mount Sinai

NCT06027788

RECRUITING Phase 2 728 participants

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

DiaMedica Therapeutics

NCT05065216

RECRUITING NA 584 participants

Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

Raul Nogueira

NCT05983757

RECRUITING 512 participants

Augmented Renal Clearance in Neurocritical Care

University of Alberta

NCT07410624

RECRUITING NA 360 participants

The Recovery in Stroke Using PAP Study

Yale University

NCT04130503

RECRUITING 350 participants

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

University of Virginia

NCT06292117

RECRUITING Phase 2 300 participants

Strategy for Improving Stroke Treatment Response

Translational Sciences

NCT05948566

RECRUITING 250 participants

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

University of California, Los Angeles

NCT05518305

RECRUITING Phase 2 200 participants

Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

Yale University

NCT04760717

RECRUITING 150 participants

Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

Johns Hopkins University

NCT05556395

RECRUITING NA 150 participants

Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors

Massachusetts General Hospital

NCT07414732

RECRUITING Phase 2 132 participants

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial

ProMedica Health System

NCT06949228

RECRUITING NA 122 participants

EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment

BrainQ Technologies

NCT06386874

RECRUITING NA 80 participants

Personalized Transcranial Direct Current Stimulation in Stroke Recovery

The Methodist Hospital Research Institute

NCT06286800

RECRUITING NA 72 participants

External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients

Johns Hopkins University

NCT06899711

RECRUITING NA 70 participants

Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke

University of Pennsylvania

NCT04897334

RECRUITING NA 70 participants

K01 Impacts of Lingual Endurance Exercise

University of Cincinnati

NCT06072924

RECRUITING Phase 1 60 participants

Verapamil for Neuroprotection in Stroke

Global Neurosciences Institute

NCT03347786

RECRUITING 50 participants

Imaging the Pathogenesis of Cerebral Small Vessel Disease

Johns Hopkins University

NCT05703386

RECRUITING 45 participants

Post-Stroke Sensory Reweighting on Walking and Balance Outcomes

University of Cincinnati

NCT06727097

RECRUITING NA 42 participants

Wireless Nerve Stimulation Device To Enhance Recovery After Stroke

Baylor Research Institute

NCT04534556

RECRUITING 40 participants

OsciPulse D-dimer Pilot Trial

University of Pennsylvania

NCT06477016

RECRUITING NA 20 participants

A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke

Mayo Clinic

NCT07291024

RECRUITING Phase 1 20 participants

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Johns Hopkins University

NCT07053917

RECRUITING NA 15 participants

Virtual Reality Based Rehabilitation After Ischemic Stroke

Stony Brook University

NCT06401564

ACTIVE NOT RECRUITING NA 6,573 participants

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

AtriCure

NCT05478304

ACTIVE NOT RECRUITING NA 3,062 participants

Sleep for Stroke Management and Recovery Trial

University of Michigan

NCT03812653

ACTIVE NOT RECRUITING 1,500 participants

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites

University of Cincinnati

NCT00642213

ACTIVE NOT RECRUITING NA 168 participants

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

Rapid Medical

NCT05152524

ACTIVE NOT RECRUITING 114 participants

Symptomatic Carotid Outcomes Registry

University of Maryland, Baltimore

NCT05300737

ACTIVE NOT RECRUITING 72 participants

Florida Cerebrovascular Disease Biorepository and Genomics Center

Mayo Clinic

NCT05491980

ACTIVE NOT RECRUITING 50 participants

VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home

MicroTransponder

NCT05691023

ACTIVE NOT RECRUITING Phase 1 30 participants

A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)

Gary Steinberg, MD, PhD

NCT04631406

ACTIVE NOT RECRUITING Early Phase 1 20 participants

Memantine for Enhanced Stroke Recovery

University of Utah

NCT02144584

ACTIVE NOT RECRUITING Phase 1 16 participants

A Study of NCS-01 in Patients With Acute Ischemic Stroke

NC Medial Research

NCT03915431

ACTIVE NOT RECRUITING NA 6 participants

Addressing Sleep Apnea Post-Stroke/TIA

VA Office of Research and Development

NCT04322162

COMPLETED 1,877 participants

Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research

Duke University

NCT02146274

COMPLETED Phase 4 1,500 participants

Quality Improvement in Stroke Prevention (QUISP)

University of California, San Francisco

NCT00328640

COMPLETED Phase 4 630 participants

Patent Foramen Ovale in Cryptogenic Stroke Study

Columbia University

NCT00697151

COMPLETED NA 552 participants

Discharge Educational Strategies for Reduction of Vascular Events

NYU Langone Health

NCT01836354

COMPLETED 400 participants

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

Penumbra

NCT04693767

COMPLETED NA 300 participants

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

Mercy Health Ohio

NCT03805308

COMPLETED NA 160 participants

Treatment With Intent to Generate Endovascular Reperfusion

Rapid Medical

NCT03474549

COMPLETED Phase 4 108 participants

Assess the Penumbra System in the Treatment of Acute Stroke

Penumbra

NCT01429350

COMPLETED NA 100 participants

The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE "EMAGINE" STUDY)

BrainQ Technologies

NCT05044507

Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 10
Phase 2 9
Phase 4 3

Named interventions

Most-linked intervention names on Ischemic Stroke records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Aspirin Drug
2 trials
Dilitazem Drug
1 trials
DESERVE education Behavioral
1 trials
dalfampridine-ER/placebo Drug
1 trials
placebo/dalfampridine-ER Drug
1 trials
intra-arterial tenecteplase Drug
1 trials
HBOT and OMT Combination
1 trials
eptifibatide Drug
1 trials

US sites by state

Facility locations filed on Ischemic Stroke trials. A trial with sites in several states counts in each.

California 19 trials
New York 16 trials
Florida 15 trials
Ohio 12 trials
Illinois 12 trials
Pennsylvania 11 trials
Massachusetts 11 trials
Georgia 11 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ischemic Stroke page

67 registered trials, 30 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemic Stroke condition card totals 67 registered trials; most-linked intervention Aspirin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.